World's Best Scientists 2026 revealed!
Michael R. Zalutsky

Michael R. Zalutsky

D-Index & Metrics

Medicine

D-Index
84
Citations
21197
World Ranking
15291
National Ranking
7715

Michael R. Zalutsky publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael R. Zalutsky sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 457 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael R. Zalutsky D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Zalutsky sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael R. Zalutsky is affiliated with Duke University in the United States and has a research profile centered primarily in the field of Medicine. Their work covers multiple subfields, including Radiology, Nuclear Medicine and Imaging, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, and Genetics.

The main topics of their research include:

  • Radiopharmaceutical Chemistry and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • HER2/EGFR in Cancer Research
  • Medical Imaging Techniques and Applications
  • Medical Imaging and Pathology Studies
  • Prostate Cancer Treatment and Research
  • Peptidase Inhibition and Analysis

Their publications have appeared frequently in the following venues:

  • Nuclear Medicine and Biology
  • Journal of Nuclear Medicine
  • Frontiers in Pharmacology
  • Nature Biomedical Engineering
  • Scientific Reports

Some of the recent papers by Michael R. Zalutsky include:

  • Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy, 2020, Frontiers in Pharmacology
  • Production, purification and availability of 211At: Near term steps towards global access, 2021, Nuclear Medicine and Biology
  • An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy, 2021, Journal of Nuclear Medicine
  • Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours, 2022, Nature Biomedical Engineering
  • Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer, 2021, Nuclear Medicine and Biology

Frequent collaborators in their research include:

  • Ganesan Vaidyanathan
  • Yutian Feng
  • Zhengyuan Zhou
  • Rebecca Meshaw
  • Darryl McDougald

Best Publications

  • Monoclonal Antibodies against EGFRvIII Are Tumor Specific and React with Breast and Lung Carcinomas and Malignant Gliomas

    Carol J. Wikstrand;Laura P. Hale;Surinder K. Batra;M. Leslie Hill

  • Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

    Peter A. Humphrey;Albert J. Wong;Bert Vogelstein;Michael R. Zalutsky

  • Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6

    Michael R. Zalutsky;David A. Reardon;Gamal Akabani;R. Edward Coleman

  • Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT

    R J Jaszczak;Jianying Li;Huili Wang;M R Zalutsky

  • Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly Diagnosed Malignant Gliomas

    David A. Reardon;Gamal Akabani;R. Edward Coleman;Allan H. Friedman

  • Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

    John H. Sampson;Gamal Akabani;Gary E. Archer;Darell D. Bigner

  • Targeting a Genetically Engineered Elastin-like Polypeptide to Solid Tumors by Local Hyperthermia

    Dan E. Meyer;Garheng A. Kong;Mark W. Dewhirst;Michael R. Zalutsky

  • A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy

    Yang Liu;Jeffrey R Ashton;Everett J Moding;Hsiangkuo Yuan

  • Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody.

    David Colcher;Michael Zalutsky;William Kaplan;Donald Kufe

  • Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primary and Metastatic Malignant Brain Tumors: Phase II Study Results

    David A. Reardon;Gamal Akabani;R. Edward Coleman;Allan H. Friedman

  • Astatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy

    Michael Zalutsky;Ganesan Vaidyanathan

  • The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target

    C J Wikstrand;C J Reist;G E Archer;M R Zalutsky

  • A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.

    Michael R. Zalutsky;Acharan S. Narula

  • Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.

    D D Bigner;M T Brown;A H Friedman;R E Coleman

  • A thermally responsive biopolymer for intra-articular drug delivery.

    Helawe Betre;Wenge Liu;Michael R. Zalutsky;Ashutosh Chilkoti

  • Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

    John H. Sampson;Gamal Akabani;Gerald E. Archer;Mitchel S. Berger

  • Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.

    Michael R. Zalutsky;Pradeep K. Garg;Henry S. Friedman;Darell D. Bigner

  • Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

    Ilkcan Cokgor;Gamal Akabani;Chien-Tsun Kuan;Henry S. Friedman

  • Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides

    Marie Boyd;Susan C Ross;Jennifer Dorrens;Natasha E Fullerton

  • Molecular Imaging of Hypoxia

    Satish K. Chitneni;Gregory M. Palmer;Michael R. Zalutsky;Mark W. Dewhirst

Frequent Co-Authors

Darell D. Bigner
Darell D. Bigner Duke University
Henry S. Friedman
Henry S. Friedman Duke University
Roger E. McLendon
Roger E. McLendon Duke University
Allan H. Friedman
Allan H. Friedman Duke University
Ashutosh Chilkoti
Ashutosh Chilkoti Duke University
Mark W. Dewhirst
Mark W. Dewhirst Duke University
David A. Reardon
David A. Reardon Harvard University
R. Edward Coleman
R. Edward Coleman Duke University
James E. Herndon
James E. Herndon Duke University
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring allied health and related online degrees can open flexible pathways for those interested in medicine or healthcare. For those without a nursing background, msn direct entry programs online let you fast-track into advanced nursing roles without prior RN experience.

If you’re aiming for a straightforward entry to nursing, direct admit nursing programs often feature simplified admission criteria, helping you start your career sooner. Some programs even allow you to bypass entrance exams like the TEAS or HESI—find out more about whether do i need to take the teas test for lpn entry at select schools.

Healthcare extends beyond patient care—administrative roles are also in demand. Pursuing education at medical billing and coding online schools can prepare you for vital support careers, often with flexible, remote learning options.

Each of these pathways can provide rewarding healthcare careers while accommodating diverse lifestyles or educational backgrounds.

Best Scientists Citing Michael R. Zalutsky

Trending Scientists

Recently Published Articles